• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[学业成绩不佳:最新综述]

[Poor school performance: an updated review].

作者信息

Siqueira Cláudia Machado, Gurgel-Giannetti Juliana

机构信息

Universidade Federal de Minas Gerais.

出版信息

Rev Assoc Med Bras (1992). 2011 Jan-Feb;57(1):78-87.

PMID:21390464
Abstract

This study aims to develop a comprehensive review on the issue of poor school performance for professionals in both health and education areas. It discusses current aspects of education, learning and the main conditions involved in underachievement. It also presents updated data on key aspects of neurobiology, epidemiology, etiology, clinical presentation, comorbidities and diagnosis, early intervention and treatment of the major pathologies comprised. It is a comprehensive, non-systematic literature review on learning, school performance, learning disorders (dyslexia, dyscalculia and dysgraphia), attention deficit / hyperactivity disorder (ADHD) and developmental coordination disorder (DCD). Poor school performance is a frequent problem faced by our children, causing serious emotional, social and economic issues. An updated view of the subject facilitates clinical reasoning, accurate diagnosis and appropriate treatment.

摘要

本研究旨在针对健康和教育领域的专业人士,就学业成绩不佳这一问题开展全面综述。它讨论了教育、学习的当前状况以及学业成绩未达预期所涉及的主要条件。它还展示了有关神经生物学、流行病学、病因学、临床表现、共病及诊断、主要病症的早期干预和治疗等关键方面的最新数据。这是一篇关于学习、学业成绩、学习障碍(诵读困难、计算障碍和书写障碍)、注意力缺陷/多动障碍(ADHD)和发育性协调障碍(DCD)的全面而非系统性的文献综述。学业成绩不佳是我们的孩子经常面临的问题,会引发严重的情感、社会和经济问题。对该主题的最新观点有助于临床推理、准确诊断和恰当治疗。

相似文献

1
[Poor school performance: an updated review].[学业成绩不佳:最新综述]
Rev Assoc Med Bras (1992). 2011 Jan-Feb;57(1):78-87.
2
Clinical practice guideline: diagnosis and evaluation of the child with attention-deficit/hyperactivity disorder. American Academy of Pediatrics.临床实践指南:注意缺陷/多动障碍儿童的诊断与评估。美国儿科学会。
Pediatrics. 2000 May;105(5):1158-70. doi: 10.1542/peds.105.5.1158.
3
Parent training interventions for Attention Deficit Hyperactivity Disorder (ADHD) in children aged 5 to 18 years.针对5至18岁儿童注意力缺陷多动障碍(ADHD)的家长培训干预措施。
Cochrane Database Syst Rev. 2011 Dec 7;2011(12):CD003018. doi: 10.1002/14651858.CD003018.pub3.
4
Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).哌醋甲酯治疗注意缺陷多动障碍(ADHD)儿童和青少年。
Cochrane Database Syst Rev. 2023 Mar 27;3(3):CD009885. doi: 10.1002/14651858.CD009885.pub3.
5
Methylphenidate for children and adolescents with autism spectrum disorder.用于治疗自闭症谱系障碍儿童和青少年的哌醋甲酯
Cochrane Database Syst Rev. 2017 Nov 21;11(11):CD011144. doi: 10.1002/14651858.CD011144.pub2.
6
Education support services for improving school engagement and academic performance of children and adolescents with a chronic health condition.改善患有慢性病的儿童和青少年的学校参与度和学业成绩的教育支持服务。
Cochrane Database Syst Rev. 2023 Feb 8;2(2):CD011538. doi: 10.1002/14651858.CD011538.pub2.
7
Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of adverse events in non-randomised studies.用于治疗儿童和青少年注意力缺陷多动障碍(ADHD)的哌甲酯——非随机研究中不良事件的评估
Cochrane Database Syst Rev. 2018 May 9;5(5):CD012069. doi: 10.1002/14651858.CD012069.pub2.
8
EEG-Guided Adaptive Learning: A New Neuroeducational Approach to the Facilitation of Cognitive Control in ADHD Children.脑电图引导的适应性学习:一种促进多动症儿童认知控制的新神经教育方法。
Child Care Health Dev. 2025 Jul;51(4):e70113. doi: 10.1111/cch.70113.
9
Stimulant and non-stimulant drug therapy for people with attention deficit hyperactivity disorder and epilepsy.兴奋剂和非兴奋剂药物治疗注意缺陷多动障碍和癫痫患者。
Cochrane Database Syst Rev. 2022 Jul 13;7(7):CD013136. doi: 10.1002/14651858.CD013136.pub2.
10
Atypical antipsychotics for disruptive behaviour disorders in children and youths.用于儿童和青少年破坏性行为障碍的非典型抗精神病药物。
Cochrane Database Syst Rev. 2012 Sep 12(9):CD008559. doi: 10.1002/14651858.CD008559.pub2.

引用本文的文献

1
The neuropsychological functions of schoolchildren after the reopening of brazilian schools during the Covid-19 pandemic.巴西学校在新冠疫情后复课对学童神经心理学功能的影响。
Codas. 2023 Nov 10;36(2):e20220334. doi: 10.1590/2317-1782/20232022334pt. eCollection 2023.
2
Attention deficit in primary-school-age children with attention deficit hyperactivity disorder measured with the attention network test: a systematic review and meta-analysis.使用注意力网络测试评估注意力缺陷多动障碍小学学龄儿童的注意力缺陷:一项系统评价和荟萃分析。
Front Neurosci. 2023 Dec 7;17:1246490. doi: 10.3389/fnins.2023.1246490. eCollection 2023.
3
Attention deficit in children with attention deficit hyperactivity disorder at primary school age measured with the attention network test (ANT): A protocol for a systematic review and meta-analysis.
注意缺陷多动障碍儿童在小学年龄阶段的注意力缺陷的测量:注意力网络测试(ANT):系统评价和荟萃分析的方案。
PLoS One. 2022 Oct 25;17(10):e0275599. doi: 10.1371/journal.pone.0275599. eCollection 2022.
4
Behavioral aspects and learning motivation: a study of middle school adolescents.行为表现和学习动机:对中学生的研究。
Codas. 2022 Apr 8;34(5):e20210119. doi: 10.1590/2317-1782/20212021119. eCollection 2022.
5
Effect of cognitive behavioral intervention on electroencephalographic band powers of children with learning difficulty under eyes-closed and eyes-open conditions.认知行为干预对闭眼和睁眼状态下学习困难儿童脑电波段功率的影响。
Arq Neuropsiquiatr. 2022 Mar;80(3):224-232. doi: 10.1590/0004-282X-ANP-2020-0503.
6
Phoniatric evaluation: relationships between a set of tests and academic difficulties.语音学评估:一组测试与学习困难之间的关系。
Braz J Otorhinolaryngol. 2023 Jan-Feb;89(1):104-113. doi: 10.1016/j.bjorl.2021.10.004. Epub 2021 Nov 15.
7
The efficacy of Ritalin in ADHD children under neurofeedback training.神经反馈训练下利他林治疗 ADHD 儿童的疗效。
Neurol Sci. 2018 Dec;39(12):2071-2078. doi: 10.1007/s10072-018-3539-3. Epub 2018 Sep 5.
8
QUALITY OF LIFE AND HEALTH SELF-PERCEPTION IN CHILDREN WITH POOR SCHOOL PERFORMANCE.学习成绩不佳儿童的生活质量与健康自我认知
Rev Paul Pediatr. 2017 Oct-Dec;35(4):415-421. doi: 10.1590/1984-0462/;2017;35;4;00009.